BALTIMORE – April 15, 2013 – Warschawski, a full service branding, marketing, public relations, advertising and interactive agency, announced today the addition of a new account to its agency roster. The pre-clinical research and drug development services company, ImQuest BioSciences Inc., will work with Warschawski on brand research, key messaging and brand positioning. Terms of the agreement were not disclosed.
Warschawski will lead strategic brand-building work for ImQuest BioSciences, a Frederick, MD based biosciences organization that researches and develops drugs, vaccines and biologic products. The company specializes in developing anti-infective, anti-cancer, and anti-inflammatory agents through all phases, from discovery through pre-clinical and clinical development.
“ImQuest BioSciences is a global leader in contract research for the biotech and pharmaceutical industries and we are thrilled to work with them to help define their brand,” says David Warschawski, CEO of Warschawski. “By helping our clients get clarity of brand and brand values, we enable them to consistently reinforce an emotional connection that makes them stand out and build their businesses. We look forward to working with ImQuest to provide a fundamental component of successful marketing communications so the growing company can achieve its business goals.”
ABOUT WARSCHAWSKI (www.warschawski.com)
Warschawski is dedicated to providing clients with the highest quality of branding, marketing, PR, advertising, interactive and creative design services. Warschawski has won the top recognition of being named “U.S. Small Agency of the Year” for four of the past six years. For ten consecutive years, it also has been ranked as one of the top 30 “Best Agencies to Work For” in the U.S. In 2010, Warschawski was named “U.S. Small Agency of the Year” and the “Best Small Agency to Work For” in the U.S. The company, whose clients include Fortune 500 and Inc. 500 companies, has won more than 200 awards for its marketing communications work over the last 15 years. Warschawski was founded in 1996 and is headquartered in Baltimore, MD.
ABOUT IMQUEST BIOSCIENCES (www.imquestbio.com)
ImQuest BioSciences, based in Frederick, Maryland, is a contract research organization (CRO) focused on the development of agents for the prevention and treatment of infectious disease, cancer, and inflammatory disease, as well as specialized capabilities to support the preformulation and formulation development for optimal product delivery. The company’s proprietary ImQuestSUCCESS platform has assisted their clients in expediting the development of products for clinical evaluation through rapid identification of candidates with a high probability of clinical success by reducing the risk associated with failure experienced during clinical development. ImQuest was named Small Business of the Year by the Tech Council of Maryland (2011) and Best Places to Work (2012) by Frederick County, Maryland. Robert W. Buckheit, Jr., Ph.D., Founder and President, was Frederick’s Entrepreneur of the Year in 2011.